Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest

Critical Care Clinics

Volumn 28, Issue 2, 2012, Pages 245-270

  Gazmuri, Raúl J ^a,b   Radhakrishnan, Jeejabai ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Captain James A Lovell Federal Health Care Center   (United States)

Author keywords

Cardiopulmonary resuscitation; Energy metabolism; Erythropoietin; Ischemia; Mitochondria; Myocardium; Reperfusion injury; Sodium hydrogen antiporter; Ventricular function

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CARDIOLIPIN; CARIPORIDE; CASPASE 9; CYTOCHROME C; CYTOCHROME C OXIDASE; DOBUTAMINE; ENDONUCLEASE G; ERYTHROPOIETIN; FLAVINE ADENINE NUCLEOTIDE; MILRINONE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL; SODIUM ION; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

APOPTOSIS; ARTERIAL CARBON DIOXIDE TENSION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOPULMONARY HEMODYNAMICS; CELL DEATH; CELL VIABILITY; CORONARY ARTERY BLOOD FLOW; CYTOSOL; DIASTOLIC DYSFUNCTION; ELECTRON TRANSPORT; ENERGY METABOLISM; HEART ARREST; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DEPOLARIZATION; HEART DILATATION; HEART DISEASE; HEART INDEX; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HEART MITOCHONDRION; HEART MUSCLE; HEART STROKE VOLUME; HUMAN; HYPOTHERMIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PH; POST RESUSCITATION MYOCARDIAL DYSFUNCTION; PRIORITY JOURNAL; PROTEIN SECRETION; REPERFUSION INJURY; RESUSCITATION; REVIEW; SODIUM CELL LEVEL; SURVIVAL; SYSTOLIC DYSFUNCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOPULMONARY RESUSCITATION; ENERGY METABOLISM; ERYTHROPOIETIN; HEART ARREST; HUMANS; MITOCHONDRIA; MITOCHONDRIA, HEART; PROTEIN ISOFORMS; SODIUM-HYDROGEN ANTIPORTER; TREATMENT OUTCOME;

EID: 84858595301     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.02.001     Document Type: Review

References (124)

1. Dong Z., Saikumar P., Weinberg J.M., et al. Calcium in cell injury and death. Annu Rev Pathol 2006, 1:405-434.
2. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006, 34(Pt 2):232-237.
3. Weisfeldt M.L., Zweier J., Ambrosio G., et al. Evidence that free radicals result in reperfusion injury in heart muscle. Basic Life Sci 1988, 49:911-919.
4. Vendelin M., Beraud N., Guerrero K., et al. Mitochondrial regular arrangement in muscle cells: a "crystal-like" pattern. Am J Physiol Cell Physiol 2005, 288(3):C757-C767.
5. Frezza C., Cipolat S., Martins de B.O., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126(1):177-189.
6. Mannella C.A. The relevance of mitochondrial membrane topology to mitochondrial function. Biochim Biophys Acta 2006, 1762(2):140-147.
7. Cai J., Yang J., Jones D.P. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1998, 1366(1-2):139-149.
8. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281(5381):1309-1312.
9. Gao W., Pu Y., Luo K.Q., et al. Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J Cell Sci 2001, 114(Pt 15):2855-2862.
10. Bialik S., Cryns V.L., Drincic A., et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res 1999, 85(5):403-414.
11. Martinou I., Desagher S., Eskes R., et al. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J Cell Biol 1999, 144(5):883-889.
12. Charles I., Khalyfa A., Kumar D.M., et al. Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. Invest Ophthalmol Vis Sci 2005, 46(4):1330-1338.
13. 2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem 2004, 279(51):53103-53108.
14. de Moissac D., Gurevich R.M., Zheng H., et al. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000, 32(1):53-63.
15. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999, 99(22):2934-2941.
16. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91(4):479-489.
17. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424.
18. Zou H., Li Y., Liu X., et al. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999, 274(17):11549-11556.
19. Radhakrishnan J., Wang S., Ayoub I.M., et al. Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol 2007, 292:H767-H775.
20. Radhakrishnan J., Ayoub I.M., Gazmuri R.J. Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2009, 296(4):H1164-H1174.
21. Barczyk K., Kreuter M., Pryjma J., et al. Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 2005, 116(2):167-173.
22. Renz A., Berdel W.E., Kreuter M., et al. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001, 98(5):1542-1548.
23. Alleyne T., Joseph J., Sampson V. Cytochrome-c detection: a diagnostic marker for myocardial infarction. Appl Biochem Biotechnol 2001, 90(2):97-105.
24. Adachi N., Hirota M., Hamaguchi M., et al. Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 2004, 342(1-2):127-136.
25. Hosoya M., Nunoi H., Aoyama M., et al. Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J 2005, 24(5):467-470.
26. Hosoya M., Kawasaki Y., Katayose M., et al. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child 2006, 91(6):469-472.
27. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999, 341:233-249.
28. Halestrap A.P. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 1999, 66:181-203.
29. Korsmeyer S.J., Wei M.C., Saito M., et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000, 7(12):1166-1173.
30. Mikhailov V., Mikhailova M., Pulkrabek D.J., et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001, 276(21):18361-18374.
31. Lesnefsky E.J., Slabe T.J., Stoll M.S., et al. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 2001, 280(6):H2770-H2778.
32. Lesnefsky E.J., Chen Q., Slabe T.J., et al. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 2004, 287(1):H258-H267.
33. Paradies G., Petrosillo G., Pistolese M., et al. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res 2004, 94(1):53-59.
34. Binak K., Harmanci N., Sirmaci N., et al. Oxygen extraction rate of the myocardium at rest and on exercise in various conditions. Br Heart J 1967, 29(3):422-427.
35. Yusa T., Obara S. Myocardial oxygen extraction rate under general anesthesia. Tohoku J Exp Med 1981, 133(3):321-324.
36. Hoffman J.I.E. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984, 70:153-159.
37. Duggal C., Weil M.H., Gazmuri R.J., et al. Regional blood flow during closed-chest cardiac resuscitation in rats. J Appl Physiol 1993, 74:147-152.
38. Ditchey R.V., Goto Y., Lindenfeld J. Myocardial oxygen requirements during experimental cardiopulmonary resuscitation. Cardiovasc Res 1992, 26:791-797.
39. Gazmuri R.J., Berkowitz M., Cajigas H. Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med 1999, 27(8):1542-1550.
40. Klouche K., Weil M.H., Sun S., et al. Evolution of the stone heart after prolonged cardiac arrest. Chest 2002, 122(3):1006-1011.
41. Ayoub I.M., Kolarova J.D., Yi Z., et al. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 2003, 107:1804-1809.
42. Cooley D.A., Reul G.J., Wukasch D.C. Ischemic contracture of the heart: "stone heart.". Am J Cardiol 1972, 29:575-577.
43. Katz A.M., Tada M. The "stone heart": a challenge to the biochemist. Am J Cardiol 1972, 29:578-580.
44. Sorrell V.L., Altbach M.I., Kern K.B., et al. Images in cardiovascular medicine: continuous cardiac magnetic resonance imaging during untreated ventricular fibrillation. Circulation 2005, 111(19):e294.
45. Koretsune Y., Marban E. Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]i elevation and ATP depletion. Am J Physiol 1990, 258:H9-H16.
46. Ayoub I.M., Kolarova J., Kantola R., et al. Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes post-resuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med 2007, 35:2329-2336.
47. Gazmuri R.J. Effects of repetitive electrical shocks on postresuscitation myocardial function. Crit Care Med 2000, 28(11 Suppl):N228-N232.
48. Gazmuri R.J., Deshmukh S., Shah P.R. Myocardial effects of repeated electrical defibrillations in the isolated fibrillating rat heart. Crit Care Med 2000, 28:2690-2696.
49. Kolarova J.D., Ayoub I.M., Gazmuri R.J. Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship. Am J Physiol Heart Circ Physiol 2005, 288:H2904-H2911.
50. Takino M., Okada Y. Firm myocardium in cardiopulmonary resuscitation. Resuscitation 1996, 33:101-106.
51. 2 as an index of coronary perfusion pressure. Am J Emerg Med 1985, 3(2):147-149.
52. Gudipati C.V., Weil M.H., Bisera J., et al. Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation 1988, 77:234-239.
53. Rubertsson S., Karlsten R. Increased cortical cerebral blood flow with LUCAS: a new device for mechanical chest compressions compared to standard external compressions during experimental cardiopulmonary resuscitation. Resuscitation 2005, 65(3):357-363.
54. van Alem A.P., Post J., Koster R.W. VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation 2003, 59(2):181-188.
55. Gazmuri R.J., Weil M.H., Bisera J., et al. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996, 24(6):992-1000.
56. Kern K.B., Hilwig R.W., Rhee K.H., et al. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996, 28:232-240.
57. Laurent I., Monchi M., Chiche J.D., et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002, 40(12):2110-2116.
58. Ruiz-Bailen M., Aguayo d.H., Ruiz-Navarro S., et al. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 2005, 66(2):175-181.
59. Xu T., Tang W., Ristagno G., et al. Postresuscitation myocardial diastolic dysfunction following prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 2008, 36(1):188-192.
60. Hilwig R.W., Berg R.A., Kern K.B., et al. Endothelin-1 vasoconstriction during swine cardiopulmonary resuscitation improves coronary perfusion pressures but worsens postresuscitation outcome. Circulation 2000, 101(17):2097-2102.
61. Kern K.B., Hilwig R.W., Berg R.A., et al. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997, 95(12):2610-2613.
62. Vasquez A., Kern K.B., Hilwig R.W., et al. Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction. Resuscitation 2004, 61(2):199-207.
63. Studer W., Wu X., Siegemund M., et al. Influence of dobutamine on the variables of systemic haemodynamics, metabolism, and intestinal perfusion after cardiopulmonary resuscitation in the rat. Resuscitation 2005, 64(2):227-232.
64. Niemann J.T., Garner D., Khaleeli E., et al. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscitation myocardial dysfunction. Circulation 2003, 108(24):3031-3035.
65. Gazmuri R.J., Hoffner E., Kalcheim J., et al. Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med 2001, 137(1):43-55.
66. Gazmuri R.J., Ayoub I.M., Hoffner E., et al. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 2001, 104:234-239.
67. Gazmuri R.J., Ayoub I.M., Kolarova J.D., et al. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med 2002, 30(4 Suppl):S166-S171.
68. Kolarova J., Yi Z., Ayoub I.M., et al. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation. Chest 2005, 127(4):1327-1334.
69. Ayoub I.M., Kolarova J., Kantola R.L., et al. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation. Crit Care Med 2005, 33(11):2599-2605.
70. 2+ accumulation and attenuates myocardial injury. J Appl Physiol 2007, 103:55-65.
71. Singh D., Kolarova J.D., Wang S., et al. Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation. Am J Ther 2007, 14:361-368.
72. Grmec S., Strnad M., Kupnik D., et al. Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 2009, 80:631-637.
73. 2 production during cardiac arrest and resuscitation. Circulation 1989, 80:684-692.
74. Kette F., Weil M.H., Gazmuri R.J., et al. Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med 1993, 21(6):901-906.
75. Noc M., Weil M.H., Gazmuri R.J., et al. Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med 1994, 124:421-426.
76. Karmazyn M., Sawyer M., Fliegel L. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5(4):323-335.
77. Imahashi K., Kusuoka H., Hashimoto K., et al. Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 1999, 84(12):1401-1406.
78. Avkiran M., Ibuki C., Shimada Y., et al. Effects of acidic reperfusion on arrhythmias and Na(+)-K(+)-ATPase activity in regionally ischemic rat hearts. Am J Physiol 1996, 270(3 Pt 2):H957-H964.
79. An J., Varadarajan S.G., Camara A., et al. Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. Am J Physiol 2001, 281(6):H2398-H2409.
80. Gunter T.E., Buntinas L., Sparagna G., et al. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 2000, 28(5-6):285-296.
81. 2+ overload in ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 2002, 39(4):569-575.
82. Borutaite V., Brown G.C. Mitochondria in apoptosis of ischemic heart. FEBS Lett 2003, 541(1-3):1-5.
83. Nasser F.N., Walls J.T., Edwards W.D., et al. Lidocaine-induced reduction in size of experimental myocardial infarction. Am J Cardiol 1980, 46(6):967-975.
84. Hinokiyama K., Hatori N., Ochi M., et al. Myocardial protective effect of lidocaine during experimental off-pump coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 2003, 9(1):36-42.
85. Ayoub I.M., Radhakrishnan J., Gazmuri R.J. Targeting mitochondria for resuscitation from cardiac arrest. Crit Care Med 2008, 36:S440-S446.
86. Ayoub I.M., Kolarova J., Gazmuri R.J. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity. Resuscitation 2009, 81:106-110.
87. Radhakrishnan J., Kolarova J.D., Ayoub I.M., et al. AVE4454B-a novel sodium-hydrogen exchanger isoform-1 inhibitor-compared less effective than cariporide for resuscitation from cardiac arrest. Translat Res 2011, 157(2):71-80.
88. Paradis N.A., Martin G.B., Rivers E.P., et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990, 263:1106-1113.
89. Cai Z., Manalo D.J., Wei G., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003, 108(1):79-85.
90. Calvillo L., Latini R., Kajstura J., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003, 100(8):4802-4806.
91. Moon C., Krawczyk M., Ahn D., et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 2003, 100(20):11612-11617.
92. Parsa C.J., Matsumoto A., Kim J., et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003, 112(7):999-1007.
93. Tramontano A.F., Muniyappa R., Black A.D., et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 2003, 308(4):990-994.
94. Cai Z., Semenza G.L. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 2004, 109(17):2050-2053.
95. Lipsic E., van der M.P., Henning R.H., et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 2004, 44(4):473-479.
96. Parsa C.J., Kim J., Riel R.U., et al. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 2004, 279(20):20655-20662.
97. Wright G.L., Hanlon P., Amin K., et al. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 2004, 18(9):1031-1033.
98. Namiuchi S., Kagaya Y., Ohta J., et al. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 2005, 45(9):1406-1412.
99. Brines M.L., Ghezzi P., Keenan S., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97(19):10526-10531.
100. Siren A.L., Fratelli M., Brines M., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001, 98(7):4044-4049.
101. Ruscher K., Freyer D., Karsch M., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002, 22(23):10291-10301.
102. Ghezzi P., Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004, 11:S37-S44.
103. Celik M., Gokmen N., Erbayraktar S., et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002, 99(4):2258-2263.
104. Vesey D.A., Cheung C., Pat B., et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004, 19(2):348-355.
105. Abdelrahman M., Sharples E.J., McDonald M.C., et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004, 22(1):63-69.
106. Buemi M., Vaccaro M., Sturiale A., et al. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol 2002, 82(6):411-417.
107. Rui T., Feng Q., Lei M., et al. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res 2005, 65(3):719-727.
108. Li Y., Takemura G., Okada H., et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 2006, 71(4):684-694.
109. van der M.P., Lipsic E., Henning R.H., et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 2005, 46(1):125-133.
110. Hirata A., Minamino T., Asanuma H., et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006, 48(1):176-184.
111. + channels modulate cardiac mitochondrial function. Am J Physiol 1998, 275(5 Pt 2):H1567-H1576.
112. Wald M., Gutnisky A., Borda E., et al. Erythropoietin modified the cardiac action of ouabain in chronically anaemic-uraemic rats. Nephron 1995, 71(2):190-196.
113. Liu H., Zhang H.Y., Zhu X., et al. Preconditioning blocks cardiocyte apoptosis: role of K(ATP) channels and PKC-epsilon. Am J Physiol 2002, 282(4):H1380-H1386.
114. Guo D., Nguyen T., Ogbi M., et al. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol 2007, 293(4):H2219-H2230.
115. Chen C.H., Budas G.R., Churchill E.N., et al. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321(5895):1493-1495.
116. Baines C.P., Song C.X., Zheng Y.T., et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003, 92(8):873-880.
117. Ahmad N., Wang Y., Haider K.H., et al. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol 2006, 290(6):H2402-H2408.
118. Shaik Z.P., Fifer E.K., Nowak G. Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury. Am J Physiol Renal Physiol 2008, 294(2):F423-F432.
119. Kobayashi H., Miura T., Ishida H., et al. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin Exp Pharmacol Physiol 2008, 35(7):812-819.
120. Huang C.H., Hsu C.Y., Chen H.W., et al. Erythropoietin improves postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model. Shock 2007, 28(1):53-58.
121. Popp E., Vogel P., Teschendorf P., et al. Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats. Resuscitation 2007, 74(2):344-351.
122. Huang C.H., Hsu C.Y., Tsai M.S., et al. Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows. Crit Care Med 2008, 36:S467-S473.
123. Incagnoli P., Ramond A., Joyeux-Faure M., et al. Erythropoietin improved initial resuscitation and increased survival after cardiac arrest in rats. Resuscitation 2009, 80(6):696-700.
124. Cariou A., Claessens Y.E., Pene F., et al. Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 2008, 76(3):397-404.